Cardiovascular imaging technology developer Conavi Medical said that medical products distributor Japan Lifeline has submitted its Novasight Hybrid intravascular imaging system for regulatory approval in Japan.
Japan Lifeline has also signed on to exclusively distribute the intravascular ultrasound and optical coherence tomography system in the Japanese market. Conavi received U.S. Food and Drug Administration (FDA) 510(k) clearance for Novasight Hybrid earlier this year.
